ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,118Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 103

$525K Total Retail Price of All Prescriptions

Rank: 34 out of 103

516 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 516 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,839 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 577 552 1 2
OMEPRAZOLE 413 352 2 3
LISINOPRIL 408 377 3 5
LEVOTHYROXINE SODIUM 384 342 4 1
FUROSEMIDE 331 313 5 4
AMLODIPINE BESYLATE 301 277 6 6
ATENOLOL 275 265 7 14
WARFARIN SODIUM 259 228 8 7
METOPROLOL TARTRATE 231 217 9 9
TRAMADOL HCL 229 197 10 17
HYDROCODONE-ACETAMINOPHEN 213 174 S3 11 11
HYDROCHLOROTHIAZIDE 208 179 12 16
POTASSIUM CHLORIDE 201 178 13 10
METOPROLOL SUCCINATE 172 159 14 8
METFORMIN HCL 170 151 15 13
CITALOPRAM HBR 166 147 16 15
TRIAMTERENE-HCTZ 150 135 17 38
ATORVASTATIN CALCIUM 143 140 18 18
GABAPENTIN 141 123 19 22
LOSARTAN POTASSIUM 135 113 20 12
TAMSULOSIN HCL 134 129 21 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 114 22 48
ZOLPIDEM TARTRATE 127 111 23 29
CARVEDILOL 125 113 24 20
AZITHROMYCIN 115 101 25 44
ALLOPURINOL 107 100 26 26
PROAIR HFA 105 88 27 116
MIRTAZAPINE 104 91 28 36
SERTRALINE HCL 102 87 29 21
DOXAZOSIN MESYLATE 94 89 30 90
METFORMIN HCL ER 91 76 31 70
PREDNISONE 82 74 32 24
GLIPIZIDE 81 73 33 65
ADVAIR DISKUS 77 77 34 42
ISOSORBIDE MONONITRATE ER 74 65 35 37
FENOFIBRATE 72 64 36 58
DIGOXIN 71 67 37 25
SPIRONOLACTONE 65 53 38 30
DONEPEZIL HCL 64 59 39 28
GLYBURIDE 63 60 R 40 76
AMITRIPTYLINE HCL 62 54 R 41 54
SYNTHROID 60 56 42 51
METOLAZONE 57 56 43 111
VENTOLIN HFA 57 47 43 141
FLUOXETINE HCL 56 46 45 92
AGGRENOX 53 53 46 228
ALENDRONATE SODIUM 53 51 46 19
LANTUS 52 33 48 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.